In the BioHarmony Drug Report Database

"Preview" Icon

Dibotermin alfa

Inductos (dibotermin alfa) is a protein pharmaceutical. Dibotermin alfa was first approved as Inductos on 2002-09-09. It has been approved in Europe to treat internal fracture fixation, spinal fusion, and tibial fractures.

 

Trade Name

 

Inductos
 

Common Name

 

dibotermin alfa
 

ChEMBL ID

 

CHEMBL2109171
 

Indication

 

internal fracture fixation, spinal fusion, tibial fractures
 

Drug Class

 

Growth factors: bone morphogenetic proteins|growth factors: transforming growth factors

Image (chem structure or protein)

Dibotermin alfa structure rendering